Pyrrole compounds and uses thereof

Details for Australian Patent Application No. 2004247627 (hide)

Owner Ambit Biosciences Corporation

Inventors Mehta, Shamal Anil; Patel, Hitesh K.; Biggs, William H. III; Zarrinkar, Patrick Parvis; Fabian, Miles A.; Lockhart, David J.; Milanov, Zdravko V.; Ciceri, Pietro; Treiber, Daniel Kelly

Agent Davies Collison Cave

Pub. Number AU-A-2004247627

PCT Pub. Number WO2004/110998

Priority 60/488,178 16.07.03 US; 60/471,425 16.05.03 US; 60/480,475 20.06.03 US; 60/516,651 30.10.03 US; 60/488,172 16.07.03 US; 60/516,616 30.10.03 US; 60/516,610 30.10.03 US; 60/480,289 20.06.03 US

Filing date 17 May 2004

Wipo publication date 23 December 2004

International Classifications

C07D 207/36 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2004/110998 Priority application(s): WO2004/110998

6 March 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247629-Grooved surface belt or roll and method of fabrication

2004247626-Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38